Delorean makes Horsley Park Bioenergy final decision, obtains $30.5M in NSW grants

Delorean Corporation (ASX:DEL) has announced a significant milestone with the final investment decision (FID) for its Horsley Park bioenergy project in New South Wales, alongside securing $30.5 million in grants from the New South Wales government and the Australian Renewable Energy Agency (ARENA). This decision marks a pivotal moment for the company as it aims to establish a new fuel source within the Australian energy network. The total project cost is estimated at $62.1 million, with Delorean now tasked with sourcing the remaining $31.6 million required for construction. The project, co-developed with Brickworks Building Products, will be located on Brickworks’ land under a 25-year lease agreement, with an offtake arrangement for biomethane to be supplied to Brickworks from the project's inception.

This announcement comes after a series of prior disclosures from Delorean, which have indicated a gradual progression towards this decision. In previous updates, the company had highlighted its ambitions to develop bioenergy solutions as part of a broader strategy to contribute to sustainable energy practices in Australia. The current announcement aligns with these earlier commitments, suggesting that Delorean is maintaining its strategic focus on renewable energy projects. However, the requirement to secure an additional $31.6 million raises questions about the company's funding capabilities, especially given its current market capitalisation of AUD 25.1 million. This funding gap could potentially signal a reliance on further capital raises, which may dilute existing shareholder value.

Financially, Delorean's position appears precarious given the substantial funding still required to move forward with the Horsley Park project. The grants secured thus far, totaling $30.5 million, represent a significant portion of the project's budget, but the remaining amount needed is nearly 126% of Delorean’s current market cap. This situation raises concerns about the company's ability to finance the project without resorting to dilutive financing options. The management has indicated that the remaining funding will come from Delorean's own sources, but without a clear outline of these sources or existing cash reserves, it is difficult to ascertain the feasibility of this plan.

When assessing Delorean's valuation in comparison to its peers, the situation becomes more complex. Currently, Delorean's market cap of AUD 25.1 million positions it as a micro-cap company within the renewable energy sector. Comparatively, Brickworks Building Products (ASX:SOL), which is a co-developer of the project, has a market cap of AUD 16.31 billion, highlighting the disparity in scale and financial resources. While Brickworks is well-positioned to absorb the operational risks associated with the project, Delorean's smaller size and limited financial resources could hinder its ability to deliver on the project’s promises.

In terms of peer comparison, the renewable energy sector includes several companies that are similarly focused on bioenergy and sustainable practices. However, finding direct peers that match Delorean’s market cap and operational stage is challenging. Companies like Energy Developments Limited (ASX:ENE) and Infigen Energy (ASX:IFN) operate within the broader renewable energy space, but their market capitalisations are significantly larger, which complicates a direct comparison. The absence of similarly sized peers in the bioenergy sector suggests that Delorean may be facing unique challenges that could affect its competitive positioning and valuation.

Delorean's execution track record has been mixed, with this announcement representing a culmination of efforts to advance its bioenergy initiatives. The company has previously communicated its intentions to develop renewable energy projects, but the actualisation of these plans has been contingent upon securing necessary funding and regulatory approvals. The current announcement does indicate a positive step forward, as it represents a formal commitment to the project, but the need for additional funding could be seen as a red flag, particularly if it leads to shareholder dilution or delays in project execution.

Looking ahead, the next expected catalyst for Delorean will likely revolve around its efforts to secure the remaining $31.6 million in funding. The timeline for this funding acquisition has not been disclosed, leaving investors in the dark regarding the pace at which the project can progress. The urgency of securing this funding will be critical, as delays could impact the overall timeline for project completion and operational commencement.

In conclusion, while the announcement of the final investment decision for the Horsley Park bioenergy project and the acquisition of $30.5 million in grants appears positive on the surface, a deeper analysis reveals significant challenges ahead for Delorean Corporation. The need for additional funding raises concerns about the company's financial health and ability to execute its plans without diluting shareholder value. Given these factors, the announcement can be classified as moderate, as it does signify progress but is overshadowed by the uncertainties surrounding funding and execution. Investors should approach this development with caution, as the headline sentiment does not fully capture the complexities of Delorean's current situation.

Key insights

• ●Delorean needs AUD 31.6M more to proceed, raising dilution concerns.
• ●The project aligns with Delorean's previous commitments but highlights funding gaps.
• ●Lack of direct peers complicates valuation and competitive positioning.

Disagree with this article?